Literature DB >> 33476536

[Influence of maternal and infant factors on CD34+ hematopoietic stem/progenitor cells in umbilical cord blood].

Jing He1, Yue-Ming Yang, Ling Liu, Dong Wang1.   

Abstract

OBJECTIVE: To study the association of different maternal and infant factors with the number of total nucleated cells and CD34+ hematopoietic stem/progenitor cells in umbilical cord blood, and to provide a reference for reasonable selection of umbilical cord blood in the cord blood bank.
METHODS: A prospective study was performed for the umbilical cord blood samples of 130 neonates who were born in Dalian Women and Children's Medical Center from June 2019 to January 2020, with a male/female ratio of 1:1. Related perinatal information was collected, including maternal age and blood type, presence or absence of gestational diabetes or gestational hypertension, pregnancy method, mode of delivery, singleton pregnancy/twin pregnancy, body weight and sex of neonates, Apgar score after birth, and the conditions of placenta, amniotic fluid, and umbilical cord.
RESULTS: The neonates were grouped according to maternal blood type, gestational diabetes, gestational hypertension, pregnancy method, mode of delivery, singleton pregnancy/ twin pregnancy, sex of neonates, Apgar score after birth, placental morphology, meconium staining of amniotic fluid, and umbilical cord around the neck. The comparison between groups showed no significant differences in the numbers of total nucleated cells and CD34+ cells in umbilical cord blood (P > 0.05). Maternal age and neonatal body weight were not correlated with the number of total nucleated cells in umbilical cord blood (P > 0.05), and neonatal body weight was not correlated with the number of CD34+ cells (P > 0.05), while maternal age was positively correlated with the number of CD34+ cells (P < 0.05).
CONCLUSIONS: The number of CD34+ cells in umbilical cord blood increases with the increase in maternal age, and therefore, umbilical cord blood in the cord blood bank may be selected based on maternal age.

Entities:  

Year:  2021        PMID: 33476536      PMCID: PMC7818158     

Source DB:  PubMed          Journal:  Zhongguo Dang Dai Er Ke Za Zhi        ISSN: 1008-8830


  27 in total

1.  Maternal and neonatal factors associated with the high yield of mononuclear low-density/CD34+ cells from placental/umbilical cord blood.

Authors:  Atsuko Omori; Kenji Takahashi; Masaharu Hazawa; Naoko Misaki; Hisateru Ohba; Mami Manabe; Haruo Sato; Kaori Kudo; Tsuneo A Takahashi; Ikuo Kashiwakura
Journal:  Tohoku J Exp Med       Date:  2008-05       Impact factor: 1.848

2.  Neonatal sex and weight influence CD34(+) cell concentration in umbilical cord blood but not stromal cell-derived factor 1-3'A polymorphism.

Authors:  Fontanet Bijou; Zoran Ivanovic; Dominique Fizet; Bernard Dazey; Jean-Michel Boiron; Xavier Lafarge
Journal:  Cytotherapy       Date:  2014-10-24       Impact factor: 5.414

3.  Factors predicting the hematopoietic stem cells content of the umbilical cord blood.

Authors:  Suleimman A Al-Sweedan; Lama Musalam; Basil Obeidat
Journal:  Transfus Apher Sci       Date:  2013-02-14       Impact factor: 1.764

4.  Influence of maternal, infant, and collection characteristics on high-quality cord blood units in Guangzhou Cord Blood Bank.

Authors:  Shaoqing Wu; Guie Xie; Jieying Wu; Jingsong Chen; Yan Lu; Yan Li; Xuewei Tang; Can Liao
Journal:  Transfusion       Date:  2015-05-21       Impact factor: 3.157

5.  Circadian and circannual variations in cord blood hematopoietic cell composition.

Authors:  Sophie Servais; Etienne Baudoux; Bénédicte Brichard; Dominique Bron; Cécile Debruyn; Didier De Hemptinne; Véronique Deneys; Jean-Michel Paulus; Jean-Pierre Schaaps; Jean-Remy Van Cauwenberge; Laurence Seidel; Alain Delforge; Yves Beguin
Journal:  Haematologica       Date:  2014-09-26       Impact factor: 9.941

6.  Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group.

Authors:  E Gluckman; V Rocha; A Boyer-Chammard; F Locatelli; W Arcese; R Pasquini; J Ortega; G Souillet; E Ferreira; J P Laporte; M Fernandez; C Chastang
Journal:  N Engl J Med       Date:  1997-08-07       Impact factor: 91.245

7.  Changes in Stemness Properties, Differentiation Potential, Oxidative Stress, Senescence and Mitochondrial Function in Wharton's Jelly Stem Cells of Umbilical Cords of Mothers with Gestational Diabetes Mellitus.

Authors:  Chiou-Mee Kong; Arjunan Subramanian; Arijit Biswas; Walter Stunkel; Yap-Seng Chong; Ariff Bongso; Chui-Yee Fong
Journal:  Stem Cell Rev Rep       Date:  2019-06       Impact factor: 5.739

Review 8.  [New techniques for umbilical cord blood transplantation].

Authors:  Yuming Zhang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2013-12

9.  Factors affecting umbilical cord blood stem cell suitability for transplantation in an in utero collection program.

Authors:  Christine L Keersmaekers; Brian A Mason; Jan Keersmaekers; Matthew Ponzini; Ryan A Mlynarek
Journal:  Transfusion       Date:  2013-07-19       Impact factor: 3.157

10.  Feasibility of collecting umbilical cord blood in jordan and the effect of maternal and neonatal factors on hematopoietic stem cell content.

Authors:  Ayad Ahmed Hussein; Randa M Bawadi; Lubna H Tahtamouni; Haydar Frangoul; Ali Z Elkarmi
Journal:  Mediterr J Hematol Infect Dis       Date:  2014-02-18       Impact factor: 2.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.